153 related articles for article (PubMed ID: 26276002)
1. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.
Girdlestone J; Pido-Lopez J; Srivastava S; Chai J; Leaver N; Galleu A; Lombardi G; Navarrete CV
Cytotherapy; 2015 Sep; 17(9):1188-99. PubMed ID: 26276002
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
Hajkova M; Hermankova B; Javorkova E; Bohacova P; Zajicova A; Holan V; Krulova M
Stem Cell Rev Rep; 2017 Feb; 13(1):104-115. PubMed ID: 27866327
[TBL] [Abstract][Full Text] [Related]
3. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.
Zheng J; Li H; He L; Huang Y; Cai J; Chen L; Zhou C; Fu H; Lu T; Zhang Y; Yao J; Yang Y
Cell Prolif; 2019 Mar; 52(2):e12546. PubMed ID: 30537044
[TBL] [Abstract][Full Text] [Related]
5. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
Eggenhofer E; Renner P; Soeder Y; Popp FC; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH
Transpl Immunol; 2011 Sep; 25(2-3):141-7. PubMed ID: 21704160
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.
Sirpilla O; Sakemura RL; Hefazi M; Huynh TN; Can I; Girsch JH; Tapper EE; Cox MJ; Schick KJ; Manriquez-Roman C; Yun K; Stewart CM; Ogbodo EJ; Kimball BL; Mai LK; Gutierrez-Ruiz OL; Rodriguez ML; Gluscevic M; Larson DP; Abel AM; Wierson WA; Olivier G; Siegler EL; Kenderian SS
Nat Biomed Eng; 2024 Apr; 8(4):443-460. PubMed ID: 38561490
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
11. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
[TBL] [Abstract][Full Text] [Related]
12. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
Sergeant E; Buysse M; Devos T; Sprangers B
Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
Taylor PA; Lees CJ; Wilson JM; Ehrhardt MJ; Campbell MT; Noelle RJ; Blazar BR
Blood; 2002 Nov; 100(9):3400-7. PubMed ID: 12384443
[TBL] [Abstract][Full Text] [Related]
18. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
19. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]